BRUKER CORPORATION Deferred Revenue
BRUKER CORPORATION (BRKR) had Deferred Revenue of $438.20 million as of 2024-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:DeferredRevenueCurrent · last filed 2025-03-03
- 2024-12-31: Deferred Revenue, Current $438.20M.
- 2024-09-30: Deferred Revenue, Current $466.70M.
- 2024-06-30: Deferred Revenue, Current $501.90M.
- 2024-03-31: Deferred Revenue, Current $485.20M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2024-12-31 | $438.20M 10-K · filed 2025-03-03 |
| 2024-09-30 | $466.70M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $501.90M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $485.20M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $400.00M 10-K · filed 2025-03-03 |
| 2023-09-30 | $381.20M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $397.40M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $397.80M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $370.20M 10-K · filed 2024-02-29 |
| 2018-12-31 | $96.30M 10-K · filed 2019-03-01 |
| 2017-12-31 | $87.00M 10-K · filed 2019-03-01 |
| 2016-12-31 | $75.50M 10-K · filed 2018-03-16 |
| 2015-12-31 | $77.00M 10-K · filed 2017-03-01 |
| 2014-12-31 | $89.00M 10-K · filed 2016-02-29 |
| 2013-12-31 | $88.10M 10-K · filed 2015-02-27 |
| 2012-12-31 | $82.50M 10-K · filed 2014-02-27 |
| 2011-12-31 | $83.00M 10-K · filed 2013-02-28 |
| 2010-12-31 | $70.30M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |